Acute myeloid leukemia with myeloid sarcoma and eosinophilia: Prolonged remission and molecular response to imatinib

Journal of Clinical Oncology

Volumn 28, Issue 3, 2010, Pages

  Védy, Dana ^a   Muehlematter, Dominique ^a   Rausch, Thierry ^b   Stalder, Michèle ^c   Jotterand, Martine ^a   Spertini, Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c Institut Central des Hopitaux Valaisans   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; IDARUBICIN; IMATINIB; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE PAIN; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CEREBROSPINAL FLUID; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EOSINOPHILIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GRANULOCYTIC SARCOMA; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KARYOTYPE; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVAGE THERAPY; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION; MIDDLE AGED;

ANTINEOPLASTIC AGENTS; EOSINOPHILIA; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; REMISSION INDUCTION; SARCOMA, MYELOID;

EID: 75749126584     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.6976     Document Type: Article

References (11)

1. Vandenberghe P, Wlodarska I, Michaux L, et al: Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 18:734-742, 2004
2. Parker JE, Pagliuca A, Mijovic A, et al: Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia Br J Haematol 99:939-944, 1997
3. Tefferi A, Vardiman JW: Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22:14-22, 2008
4. Swerdlow S, Campo E, Harris N, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Press 2008, pp 1-439
5. Cools J, DeAngelo DJ, Gotlib J, et al: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201-1214, 2003
6. Doorduijn JK, van Lom K, Lowenberg B: Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years. Br J Haematol 95:531-534, 1996
7. Lynott A, Ravandi-Kashani F, Giles FJ: Malignancy: Case report: Hypereosinophilia progressing to granulocytic sarcoma and acute myelocytic leukemia with trisomy 8: A case report and review of the literature. Hematology 4:487-493, 2000
8. Fujii N, Ikeda K, Takahashi N, et al: Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8. Br J Haematol 119:716-719, 2002
9. Yamauchi K, Yasuda M: Comparison in treatments of nonleukemic granulocytic sarcoma: Report of two cases and a review of 72 cases in the literature. Cancer 94:1739-1746, 2002
10. Metzgeroth G, Walz C, Score J, et al: Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia 21:1183-1188, 2007
11. von Bubnoff N, Sandherr M, Schlimok G, et al: Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia. Leukemia 19:286-287, 2005